-
公开(公告)号:US06927217B2
公开(公告)日:2005-08-09
申请号:US10271467
申请日:2002-10-16
申请人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Elizabeth Ann Lunney , Alexander Pavlovsky , Vara Prasad Venkata Nagendra Josyula , Bradley Dean Tait
发明人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Elizabeth Ann Lunney , Alexander Pavlovsky , Vara Prasad Venkata Nagendra Josyula , Bradley Dean Tait
IPC分类号: A61P31/12 , A61P31/18 , C07D309/32 , C07D401/06 , A61K31/351 , C07D401/04 , C07D403/04
CPC分类号: C07D309/32
摘要: The present invention relates to novel dihydropyrones of Formula I wherein X is NH or NR8, which inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS.
摘要翻译: 本发明涉及式I的新型二氢呋喃,其中X是NH或NR 8,其抑制HIV天冬氨酰蛋白酶阻断HIV感染性。 二氢吡喃可用于开发用于治疗病毒感染和疾病(包括AIDS)的治疗。
-
公开(公告)号:US06512006B1
公开(公告)日:2003-01-28
申请号:US09641260
申请日:2000-08-17
申请人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Elizabeth Ann Lunney , Alexander Pavlovsky , Vara Prasad Venkata Nagendra Josyula , Bradley Dean Tait
发明人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Elizabeth Ann Lunney , Alexander Pavlovsky , Vara Prasad Venkata Nagendra Josyula , Bradley Dean Tait
IPC分类号: C07D30930
CPC分类号: C07D309/32
摘要: The present invention related to novel dihydropyrones possessing 3-position nitrogen atom, which inhabit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections, and diseases, including AIDS.
摘要翻译: 本发明涉及具有3-位氮原子的新型二氢吡喃酮,其存在HIV天冬氨酰蛋白酶阻断HIV感染性。 二氢吡喃酮可用于开发用于治疗病毒感染和包括艾滋病在内的疾病的治疗。
-
公开(公告)号:US06852711B2
公开(公告)日:2005-02-08
申请号:US10299510
申请日:2002-11-19
申请人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Michael James Lovdahl , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
发明人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Michael James Lovdahl , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
IPC分类号: C07D233/64 , A61K31/351 , A61K31/381 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61P31/14 , A61P31/18 , C07D207/333 , C07D209/12 , C07D209/30 , C07D213/30 , C07D213/71 , C07D231/12 , C07D235/06 , C07D235/26 , C07D239/26 , C07D239/42 , C07D241/44 , C07D277/20 , C07D277/24 , C07D277/46 , C07D277/82 , C07D307/12 , C07D307/42 , C07D309/32 , C07D333/16 , C07D333/32 , C07D333/62 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/06 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , A61K31/33 , A61K31/35 , C07D277/00 , C07D309/00 , C07D315/00
CPC分类号: C07D405/06 , C07D309/32 , C07D405/12 , C07D405/14 , C07D407/06 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14
摘要: The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.
-
公开(公告)号:US5834506A
公开(公告)日:1998-11-10
申请号:US883743
申请日:1997-06-27
申请人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Harriet Wall Hamilton , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
发明人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Harriet Wall Hamilton , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
IPC分类号: C07D295/22 , A61K31/366 , A61K31/381 , A61K31/4178 , A61K31/4433 , A61K31/453 , A61K31/496 , A61K31/5355 , A61P31/18 , C07C39/26 , C07C43/225 , C07C49/255 , C07C59/48 , C07C59/52 , C07C59/68 , C07C69/734 , C07C69/738 , C07C233/33 , C07C381/04 , C07D233/84 , C07D233/86 , C07D241/04 , C07D295/205 , C07D309/32 , C07D405/04 , C07D405/12 , C07D409/12 , C07F7/08 , C07F7/18 , A61K31/35 , A61K31/415
CPC分类号: C07D295/205 , C07C233/33 , C07C381/04 , C07C59/48 , C07C59/52 , C07C59/68 , C07C69/738 , C07F7/1852 , C07F7/1856
摘要: This invention pertains to improved antiviral activity of 6,6-disubstituted-5,6-dihydropyran-2-ones caused by judicious placement of certain polar substituents at the 3 and/or 6 positions. The same substituents which enhance the cellular activity also diminish cytotoxicity further enhancing the desirable properties of these agents as antivirals.
-
公开(公告)号:US06528510B1
公开(公告)日:2003-03-04
申请号:US09674652
申请日:2000-11-02
申请人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Michael James Lovdahl , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
发明人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Michael James Lovdahl , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
IPC分类号: A61K31495
CPC分类号: C07D405/06 , C07D309/32 , C07D405/12 , C07D405/14 , C07D407/06 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14
摘要: The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.
摘要翻译: 本发明涉及具有改善的药理学性质的具有栓系杂环的新型二氢吡喃酮,其有效抑制HIV天冬氨酰蛋白酶阻断HIV感染性。 二氢吡喃可用于开发用于治疗病毒感染和疾病(包括AIDS)的治疗。 本发明还涉及合成二氢吡喃的方法和可用于制备最终化合物的中间体。
-
公开(公告)号:US6046355A
公开(公告)日:2000-04-04
申请号:US124190
申请日:1998-07-28
申请人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Harriet Wall Hamilton , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
发明人: Frederick Earl Boyer, Jr. , John Michael Domagala , Edmund Lee Ellsworth , Christopher Andrew Gajda , Susan Elizabeth Hagen , Harriet Wall Hamilton , Elizabeth Ann Lunney , Larry James Markoski , Josyula Venkata Nagendra Vara Prasad , Bradley Dean Tait
IPC分类号: C07D295/22 , A61K31/366 , A61K31/381 , A61K31/4178 , A61K31/4433 , A61K31/453 , A61K31/496 , A61K31/5355 , A61P31/18 , C07C39/26 , C07C43/225 , C07C49/255 , C07C59/48 , C07C59/52 , C07C59/68 , C07C69/734 , C07C69/738 , C07C233/33 , C07C381/04 , C07D233/84 , C07D233/86 , C07D241/04 , C07D295/205 , C07D309/32 , C07D405/04 , C07D405/12 , C07D409/12 , C07F7/08 , C07F7/18 , C07D309/31
CPC分类号: C07D295/205 , C07C233/33 , C07C381/04 , C07C59/48 , C07C59/52 , C07C59/68 , C07C69/738 , C07F7/1852 , C07F7/1856
摘要: This invention pertains to improved antiviral activity of 6,6-disubstituted-5,6-dihydropyran-2-ones caused by judicious placement of certain polar substituents at the 3 and/or 6 positions.The same substituents which enhance the cellular activity also diminish cytotoxicity further enhancing the desirable properties of these agents as antivirals.
摘要翻译: 本发明涉及通过在3和/或6位明智地放置某些极性取代基引起的6,6-二取代-5,6-二氢吡喃-2-酮的改进的抗病毒活性。 增强细胞活性的相同取代基也降低了细胞毒性,从而进一步提高了这些药物作为抗病毒剂的期望性质。
-
7.HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis 失效
标题翻译: HIV蛋白酶抑制剂,含有它们的组合物,它们的药物用途和用于合成的材料公开(公告)号:US06953858B2
公开(公告)日:2005-10-11
申请号:US10166957
申请日:2002-06-11
申请人: Stacie S. Canan Koch , Therese N. Alexander , Mark Barvian , Gary Bolton , Frederick Earl Boyer, Jr. , Benjamin J. Burke , Tod Holler , Tanya M. Jewell , Vara Prasad Josyula , David J. Kucera , Maria Angelica Linton , Jeffrey J. Machak , Lennert J. Mitchell, Jr. , Sean T. Murphy , Siegfried H. Reich , Donald J. Skalitzky , John H. Tatlock , Michael D. Varney , Scott C. Virgil , Stephen E. Webber , Stephen T. Worland , Michael Melnick
发明人: Stacie S. Canan Koch , Therese N. Alexander , Mark Barvian , Gary Bolton , Frederick Earl Boyer, Jr. , Benjamin J. Burke , Tod Holler , Tanya M. Jewell , Vara Prasad Josyula , David J. Kucera , Maria Angelica Linton , Jeffrey J. Machak , Lennert J. Mitchell, Jr. , Sean T. Murphy , Siegfried H. Reich , Donald J. Skalitzky , John H. Tatlock , Michael D. Varney , Scott C. Virgil , Stephen E. Webber , Stephen T. Worland , Michael Melnick
IPC分类号: C07D277/04 , A61K31/40 , A61K31/401 , A61K31/4025 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/435 , A61K31/439 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/472 , A61K31/501 , A61K31/5377 , A61K31/541 , A61K38/04 , A61K45/00 , A61P31/00 , A61P31/12 , A61P31/18 , A61P37/02 , A61P43/00 , C07D207/09 , C07D207/16 , C07D207/24 , C07D209/52 , C07D213/38 , C07D217/26 , C07D231/12 , C07D263/04 , C07D263/06 , C07D277/00 , C07D277/06 , C07D277/20 , C07D277/28 , C07D277/32 , C07D277/38 , C07D277/60 , C07D295/13 , C07D307/52 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/08 , C07K5/04
CPC分类号: C07D231/12 , A61K31/426 , A61K31/427 , C07D207/09 , C07D207/16 , C07D213/38 , C07D217/26 , C07D277/06 , C07D277/60 , C07D295/13 , C07D307/52 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/08
摘要: Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.
摘要翻译: 公开了下式的化合物:其中式变量如本文所定义,其有利地抑制或阻断HIV蛋白酶的生物活性。 这些化合物以及含有这些化合物的药物组合物可用于治疗感染HIV病毒的患者或宿主。 还描述了制备这些化合物的中间体和合成方法。
-
公开(公告)号:US07179918B2
公开(公告)日:2007-02-20
申请号:US10166979
申请日:2002-06-11
申请人: Stacie S. Canan Koch , Therese N. Alexander , Benjamin J. Burke , Tanya M. Jewell , David J. Kucera , Maria Angelica Linton , Lennert J. Mitchell, Jr. , Siegfried H. Reich , Donald J. Skalitzky , John H. Tatlock , Michael D. Varney , Scott C. Virgil , Stephen E. Webber , Stephen T. Worland , Mark Barvian , Gary Bolton , Frederick Earl Boyer, Jr. , Jeffrey J. Machak , Tod Holler , Sean T. Murphy , Michael Melnick , Vara Prasad Josyula
发明人: Stacie S. Canan Koch , Therese N. Alexander , Benjamin J. Burke , Tanya M. Jewell , David J. Kucera , Maria Angelica Linton , Lennert J. Mitchell, Jr. , Siegfried H. Reich , Donald J. Skalitzky , John H. Tatlock , Michael D. Varney , Scott C. Virgil , Stephen E. Webber , Stephen T. Worland , Mark Barvian , Gary Bolton , Frederick Earl Boyer, Jr. , Jeffrey J. Machak , Tod Holler , Sean T. Murphy , Michael Melnick , Vara Prasad Josyula
IPC分类号: C07D207/16 , C07D221/02
CPC分类号: C07D231/12 , A61K31/426 , A61K31/427 , C07D207/09 , C07D207/16 , C07D213/38 , C07D217/26 , C07D277/06 , C07D277/60 , C07D295/13 , C07D307/52 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/08
摘要: Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.
-
-
-
-
-
-
-